Continue with your mobile number
The USFDA has issued a form 483 with 10 observations after inspection of Sun Pharma's Halol facility. The unit, however, now has a low contribution to the company’s turnover. The Halol facility was classified ‘Official Action Indicated (OAI)’ in March 2020, and was awaiting re-inspection from the US regulator. Due to the pandemic related travel restrictions, the re-inspection got delayed, and now the USFDA has issued a form 483 with observations. Sun Pharma said that the US Food and Drugs Administration (USFDA) did a Good Manufacturing Practices (GMP) inspection of Sun Pharmaceutical Industries Halol facility in Gujarat from April 26 to May 9, 2022. The Company is preparing the response to the observations, which will be submitted to the US FDA within 15 business days.
The full form of RKVY is
Which of the following term is used to referred to the number of cigarettes that can be made out of one pound of tobacco?
Sucrose consists of:
Match List-I with List-II
Choose the correct answer fr...
Vector of rice tungro disease?
Hybrid cotton in India was evolved for the first time in
Which pest causes leaves to fold longitudinally and larvae remain inside during severe infestation?
Idioscopus niveosparsus is pest of:
Most abundant part of a plant cell wall is
Which of the following term is used for the system of raising arable crops along with the fruit trees?